首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備 DDS

市場調查報告書

商品編碼

1760732

2025年經皮給藥系統全球市場報告

Transdermal Drug Delivery Systems Global Market Report 2025

出版日期: 2025年07月01日 | 出版商:

The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年，經皮給藥系統市場規模將強勁成長。到2029年，該市場規模將以8.0%的年複合成長率（CAGR）成長至550億美元。預測期內的成長將受到多種因素的推動，例如患者對非侵入性治療的偏好日益成長、慢性病患病率上升、對便捷給藥方式的需求不斷成長、疼痛管理應用的不斷拓展以及對新型給藥系統的監管支持。這段時期的主要趨勢包括個人化給藥的創新、奈米技術在改善吸收方面的應用、智慧型貼片的開發、皮膚滲透技術的進步、生物活性化合物的引入以及用於慢性病管理的穿戴式設備的進步。

預計慢性病盛行率的上升將在未來幾年推動經皮給藥系統市場的成長。糖尿病和心臟病等慢性病需要持續管理並限制日常活動。久坐不動的生活方式會導致體重增加、心血管健康不佳、代謝失衡等，加劇慢性病的發生率。經皮給藥系統用於治療此類疾病，透過皮膚持續且可控制地釋放藥物，提高患者的依從性並確保穩定的治療水準。例如，2023 年 6 月，衛生指標與評估研究所報告稱，全球有超過 5 億人患有糖尿病，預計到 2050 年這一數字將加倍，達到 13 億。因此，慢性病的流行正在推動經皮給藥系統市場的擴張。

經皮給藥系統市場的主要企業正專注於微針技術等技術進步，以改善藥物吸收和患者依從性。微針是一種微創裝置，可無痛地經皮輸送藥物，為傳統注射提供了創傷較小的替代方案。例如，2024年10月，韓國大熊製藥有限公司推出了其微針平台CLOPAM。該平台顯著提高了藥物輸送效率，最大限度地減少了注射的不適，並實現了藥物的可控和持續釋放。其目標是提供一種無痛且持續的口服或注射治療治療方法，從而提高患者的依從性和治療效果。

全球經皮給藥系統 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
最終用途產業分析
全球經皮給藥系統市場：成長率分析
全球經皮給藥系統市場表現：規模與成長，2019-2024
全球經皮給藥系統市場預測：規模與成長，2024-2029年，2034年
經皮的全球總目標市場（TAM）

第6章市場區隔

全球經皮給藥系統市場（依製劑類型、效能及預測），2019-2024 年、2024-2029 年、2034 年
藥物貼片
儲存類型
矩陣類型
微型儲層型
全球經皮給藥系統市場（依技術、績效及預測），2019-2024 年、2024-2029 年、2034 年
離子電滲
微操作
全球經皮給藥系統市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
疼痛管理
中樞神經系統
心血管疾病
禁止抽煙
全球經皮給藥系統市場：依最終使用者、績效及預測，2019-2024 年、2024-2029 年、2034 年
醫院
家庭醫療保健
製藥公司
研究機構
全球經皮給藥系統市場，依藥物貼片類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
單層藥物黏合劑
多層藥物黏合劑
全球經皮給藥系統市場儲存類型細分，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
凝膠儲液系統
液體儲存系統
固體儲存系統
全球經皮給藥系統市場，依基質類型細分，依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
聚合物基質系統
脂質基質系統
水凝膠基質系統
全球經皮給藥系統市場，按微儲庫類型細分，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
微針陣列
微乳液儲層
奈米顆粒輸注容器

第7章區域和國家分析

全球經皮給藥系統市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
全球經皮給藥系統市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章：義大利市場

第20章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章：加拿大市場

第26章南美洲市場

第27章：巴西市場

第28章中東市場

第29章：非洲市場

第30章競爭格局與公司概況

經皮給藥系統市場：競爭格局
經皮給藥系統市場：公司簡介
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章其他大型創新企業

GSK plc
3M Company
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim GmbH
Mylan NV
UCB SA
Skyepharma
Noven Pharmaceuticals Inc.
Hisamitsu Pharmaceutical Co. Inc.
Watson Pharmaceuticals Inc.
Endo International plc
Transdermal Technologies Inc.
Grunenthal GmbH
4P Therapeutics LLC
Actavis Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第34章近期市場趨勢

第 35 章高市場潛力國家、細分市場與策略

2029年經皮給藥系統市場：提供新機會的國家
2029年經皮給藥系統市場：細分領域帶來新機會
2029年經皮給藥系統市場：成長策略
- 基於市場趨勢的策略
- 競爭對手的策略

第36章附錄

簡介目錄

Product Code: r35609

Transdermal drug delivery systems are methods used to administer medication through the skin, allowing for a controlled, continuous release of the drug into the bloodstream over a period of time. These systems are typically in the form of a patch or similar device applied to the skin, which gradually releases the medication, offering benefits such as avoiding the digestive system and ensuring stable drug levels in the body.

The main types of formulations for transdermal drug delivery systems include drug-in-patch, reservoir, matrix, and microreservoir types. The drug-in-patch formulation is especially common in the consumer health market due to its convenience, making it ideal for treatments such as nicotine replacement and hormone therapy. Key technologies used in transdermal drug delivery include iontophoresis and microporation. These systems are applied in various fields, including pain management, central nervous system disorders, cardiovascular diseases, and smoking cessation, and are used in settings such as hospitals, home healthcare, pharmaceutical companies, and research institutions.

The transdermal drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides transdermal drug delivery systems market statistics, including the transdermal drug delivery systems industry global market size, regional shares, competitors with the transdermal drug delivery systems market share, detailed transdermal drug delivery systems market segments, market trends, and opportunities, and any further data you may need to thrive in the transdermal drug delivery systems industry. This transdermal drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transdermal drug delivery systems market size has grown strongly in recent years. It will grow from $37.30 billion in 2024 to $40.39 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth observed in the historical period can be attributed to factors such as an increased demand for non-invasive drug delivery, better patient adherence to treatments, enhanced bioavailability, a rise in chronic disease prevalence, and a growing preference for self-administration.

The transdermal drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $55.00 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The projected growth in the forecast period is driven by factors including a greater patient preference for non-invasive treatments, the rising prevalence of chronic diseases, an increasing demand for convenient drug delivery options, expanded uses in pain management, and regulatory support for new drug delivery systems. Key trends during this period include innovations in personalized drug delivery, the use of nanotechnology for improved absorption, the development of smart patches, advancements in skin penetration techniques, the incorporation of bioactive compounds, and breakthroughs in wearable devices for managing chronic conditions.

The increasing prevalence of chronic diseases is expected to drive the growth of the transdermal drug delivery systems market in the future. Chronic diseases, such as diabetes and heart disease, require ongoing management and limit daily activities. Factors such as sedentary lifestyles, which lead to weight gain, poor cardiovascular health, and metabolic imbalances, contribute to the rise in chronic conditions. Transdermal drug delivery systems are used in these diseases to provide a continuous, controlled release of medication through the skin, improving patient adherence and ensuring stable therapeutic levels. For example, in June 2023, the Institute for Health Metrics and Evaluation reported that over half a billion people worldwide were living with diabetes, with this number expected to double, reaching 1.3 billion by 2050. Thus, the growing prevalence of chronic diseases is driving the market expansion for transdermal drug delivery systems.

Key players in the transdermal drug delivery systems market are concentrating on technological advancements such as microneedle technology to improve drug absorption and patient compliance. Microneedles are minimally invasive devices that deliver drugs through the skin painlessly, offering a less invasive alternative to traditional injections. For example, in October 2024, Daewoong Pharmaceutical Co. Ltd., a South Korea-based company, launched its microneedle platform CLOPAM. This platform significantly enhances drug delivery efficiency, minimizes the discomfort associated with injections, and provides controlled, sustained medication release. The goal is to offer a painless and consistent alternative to oral or injectable treatments, thereby improving patient compliance and treatment effectiveness.

In August 2022, LTS Lohmann Therapie-Systeme AG, a pharmaceutical company based in Germany, acquired Tapemark Inc. for an undisclosed amount. This acquisition strengthens LTS's drug delivery capabilities, expanding its expertise in production and bolstering its position in the field of transdermal and advanced drug delivery solutions. Tapemark Inc., based in the US, specializes in the manufacturing of transdermal drug delivery systems.

Major players in the transdermal drug delivery systems market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, GSK plc, 3M Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Mylan NV, UCB S.A., Skyepharma, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies, Inc., Grunenthal GmbH, 4P Therapeutics LLC, and Actavis Inc.

North America was the largest region in the transdermal drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in transdermal drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the transdermal drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transdermal drug delivery systems market consists of sales of gels, creams, and microneedles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values generated by organizations in the defined geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transdermal Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transdermal drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transdermal drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transdermal drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Formulation Type: Drug-In-Patch; Reservoir Type; Matrix Type; Microreservoir Type
2) By Technology: Iontophoresis; Microporation
3) By Application: Pain Management; Central Nervous System; Cardiovascular Diseases; Smoking Cessation
4) By End User: Hospitals; Home Healthcare; Pharmaceutical Companies; Research Institutes
Subsegments:
1) By Drug-In-Patch: Single-layer Drug-in-Adhesive; Multi-layer Drug-in-Adhesive
2) By Reservoir Type: Gel Reservoir Systems; Liquid Reservoir Systems; Solid Reservoir Systems
3) By Matrix Type: Polymer Matrix Systems; Lipid Matrix Systems; Hydrogel Matrix Systems
4) By Microreservoir Type: Microneedle Arrays; Microemulsion Reservoirs; Nanoparticle-Infused Reservoirs
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Transdermal Drug Delivery Systems Market Characteristics

3. Transdermal Drug Delivery Systems Market Trends And Strategies

4. Transdermal Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Transdermal Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

5.1. Global Transdermal Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Transdermal Drug Delivery Systems Market Growth Rate Analysis
5.4. Global Transdermal Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Transdermal Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Transdermal Drug Delivery Systems Total Addressable Market (TAM)

6. Transdermal Drug Delivery Systems Market Segmentation

6.1. Global Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug-In-Patch
Reservoir Type
Matrix Type
Microreservoir Type
6.2. Global Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Iontophoresis
Microoperation
6.3. Global Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pain Management
Central Nervous System
Cardiovascular Diseases
Smoking Cessation
6.4. Global Transdermal Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Home Healthcare
Pharmaceutical Companies
Research Institutes
6.5. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Drug-In-Patch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
6.6. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Reservoir Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gel Reservoir Systems
Liquid Reservoir Systems
Solid Reservoir Systems
6.7. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Matrix Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymer Matrix Systems
Lipid Matrix Systems
Hydrogel Matrix Systems
6.8. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Microreservoir Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Microneedle Arrays
Microemulsion Reservoirs
Nanoparticle-Infused Reservoirs

7. Transdermal Drug Delivery Systems Market Regional And Country Analysis

7.1. Global Transdermal Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Transdermal Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transdermal Drug Delivery Systems Market

8.1. Asia-Pacific Transdermal Drug Delivery Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transdermal Drug Delivery Systems Market

9.1. China Transdermal Drug Delivery Systems Market Overview
9.2. China Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transdermal Drug Delivery Systems Market

10.1. India Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transdermal Drug Delivery Systems Market

11.1. Japan Transdermal Drug Delivery Systems Market Overview
11.2. Japan Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transdermal Drug Delivery Systems Market

12.1. Australia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transdermal Drug Delivery Systems Market

13.1. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transdermal Drug Delivery Systems Market

14.1. South Korea Transdermal Drug Delivery Systems Market Overview
14.2. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transdermal Drug Delivery Systems Market

15.1. Western Europe Transdermal Drug Delivery Systems Market Overview
15.2. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transdermal Drug Delivery Systems Market

16.1. UK Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transdermal Drug Delivery Systems Market

17.1. Germany Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transdermal Drug Delivery Systems Market

18.1. France Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transdermal Drug Delivery Systems Market

19.1. Italy Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transdermal Drug Delivery Systems Market

20.1. Spain Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transdermal Drug Delivery Systems Market

21.1. Eastern Europe Transdermal Drug Delivery Systems Market Overview
21.2. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transdermal Drug Delivery Systems Market

22.1. Russia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transdermal Drug Delivery Systems Market

23.1. North America Transdermal Drug Delivery Systems Market Overview
23.2. North America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transdermal Drug Delivery Systems Market

24.1. USA Transdermal Drug Delivery Systems Market Overview
24.2. USA Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transdermal Drug Delivery Systems Market

25.1. Canada Transdermal Drug Delivery Systems Market Overview
25.2. Canada Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transdermal Drug Delivery Systems Market

26.1. South America Transdermal Drug Delivery Systems Market Overview
26.2. South America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transdermal Drug Delivery Systems Market

27.1. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transdermal Drug Delivery Systems Market

28.1. Middle East Transdermal Drug Delivery Systems Market Overview
28.2. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transdermal Drug Delivery Systems Market

29.1. Africa Transdermal Drug Delivery Systems Market Overview
29.2. Africa Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transdermal Drug Delivery Systems Market Competitive Landscape And Company Profiles

30.1. Transdermal Drug Delivery Systems Market Competitive Landscape
30.2. Transdermal Drug Delivery Systems Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Transdermal Drug Delivery Systems Market Other Major And Innovative Companies

31.1. GSK plc
31.2. 3M Company
31.3. Teva Pharmaceutical Industries Ltd.
31.4. Boehringer Ingelheim GmbH
31.5. Mylan NV
31.6. UCB S.A.
31.7. Skyepharma
31.8. Noven Pharmaceuticals Inc.
31.9. Hisamitsu Pharmaceutical Co. Inc.
31.10. Watson Pharmaceuticals Inc.
31.11. Endo International plc
31.12. Transdermal Technologies Inc.
31.13. Grunenthal GmbH
31.14. 4P Therapeutics LLC
31.15. Actavis Inc.

32. Global Transdermal Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transdermal Drug Delivery Systems Market

34. Recent Developments In The Transdermal Drug Delivery Systems Market

35. Transdermal Drug Delivery Systems Market High Potential Countries, Segments and Strategies

35.1 Transdermal Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
35.2 Transdermal Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
35.3 Transdermal Drug Delivery Systems Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies